Global Burden of Hepatitis C - Generic HCV Drugs Price
Hepatitis C is found worldwide. The most affected regions are Africa and Central and East Asia. Depending on the country, hepatitis C infection can be concentrated in certain populations (for example, among people who inject drugs) and/or in general populations. There are multiple strains (or genotypes) of the HCV virus and their distribution varies by region.
An estimated 2%–3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings.
Hepatitis C virus (HCV) causes both acute and chronic infection. Acute HCV infection is usually asymptomatic, and is only very rarely associated with life-threatening disease. About 15–45% of infected persons spontaneously clear the virus within 6 months of infection without any treatment.
The remaining 55–85% of persons will develop chronic HCV infection. Of those with chronic HCV infection, the risk of cirrhosis of the liver is between 15–30% within 20 years.
If the body is unable to fight off the virus, then Hepatiti C treatment usually involves a combination of antiviral drugs. But it is very expensive due to its patent. For some, the drugs are vastly out of reach due to their expensive prices.
GENERIC DRUGS FOR HEPATITIS C
A generic drug is the same as a brand-name drug in dosage, safety, strength, quality, the way it works, the way it is taken and the way it should be used.
The cost of Generic Drugs is 80 to 85 percent lower than the Brand name Drugs.
Please Note: Not every brand-name drug has a generic drug
Some of the HCV Medication available in market :
Hepatitis C is found worldwide. The most affected regions are Africa and Central and East Asia. Depending on the country, hepatitis C infection can be concentrated in certain populations (for example, among people who inject drugs) and/or in general populations. There are multiple strains (or genotypes) of the HCV virus and their distribution varies by region.
An estimated 2%–3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings.
Hepatitis C virus (HCV) causes both acute and chronic infection. Acute HCV infection is usually asymptomatic, and is only very rarely associated with life-threatening disease. About 15–45% of infected persons spontaneously clear the virus within 6 months of infection without any treatment.
The remaining 55–85% of persons will develop chronic HCV infection. Of those with chronic HCV infection, the risk of cirrhosis of the liver is between 15–30% within 20 years.
High cost is the main barrier to expansion of CHCV (Chronic Hepatitis C Virus) treatment.
If the body is unable to fight off the virus, then Hepatiti C treatment usually involves a combination of antiviral drugs. But it is very expensive due to its patent. For some, the drugs are vastly out of reach due to their expensive prices.
GENERIC DRUGS FOR HEPATITIS C
A generic drug is the same as a brand-name drug in dosage, safety, strength, quality, the way it works, the way it is taken and the way it should be used.
The cost of Generic Drugs is 80 to 85 percent lower than the Brand name Drugs.
Please Note: Not every brand-name drug has a generic drug
Some of the HCV Medication available in market :
- Indian Hepcinat 400 mg Sofobuvir Tablets
- MyDekla Daclatasvir 60 mg Tablets
- Natco Natdac 60 mg Daclatasvir Tablets
- Hepcinat LP Sofosbuvir 400 mg Ledipasvir 90 mg
- HepCVir L Tablets Cipla
- Hepcvir 400mg, many others
